DuPont (DD) reported third-quarter net sales of $1.87 billion, up 4% from a year earlier, with organic sales up 5%, a one-point acceleration from 4% organic growth in the second quarter.

The global materials company again exceeded its quarterly guidance and raised its full-year 2026 outlook for the third consecutive quarter. GAAP income from continuing operations was $171 million, up 68% from $102 million a year earlier. Adjusted earnings were $2.09 a share, up 62% from $1.29.

Operating EBITDA was $469 million, up 8% from $436 million, and the operating EBITDA margin widened 80 basis points to 25.1% from 24.3%. The company said operating EBITDA increased on organic growth and productivity.

Healthcare & Water Technologies contributed $865 million of net sales, up 4%, with organic sales up 4%. Operating EBITDA in the segment was $263 million, and the margin was 30.4%. Healthcare Technologies sales rose mid-single digits on an organic basis, led by personal protection and medical packaging. Water Technologies sales rose low-single digits on strength in industrial water, semiconductor and specialty markets, partly offset by continued disruptions in the Middle East. Third-quarter 2025 net sales included a $15 million, or 2%, benefit from an order-timing shift out of the fourth quarter of 2025 tied to separation-related activities, primarily in Water Technologies.

Diversified Industrials net sales were $1.00 billion, up 4%, with organic sales up 5%, a two-point acceleration from 3% organic growth in the second quarter. Operating EBITDA was $242 million, and the margin was 24.1%, up 140 basis points from 22.7%. Building Technologies sales rose mid-single digits on an organic basis on growth in North America and Asia. Industrial Technologies sales rose mid-single digits on continued strength in aerospace and electric-vehicle battery applications. Third-quarter 2025 net sales also included a $15 million, or 2%, order-timing benefit, primarily in Industrial Technologies.

Cash provided by operating activities from continuing operations was $410 million, up 27% from $322 million a year earlier. After $71 million of capital expenditures and $2 million of separation-related transaction costs and other payments, transaction-adjusted free cash flow was $341 million, with conversion of 121%.

GAAP income from continuing operations improved on higher segment earnings and lower interest expense and transaction costs. Adjusted EPS increased on higher segment earnings and lower net interest expense, tax rate, and share count.

Chief Executive Officer Lori Koch said mid-single-digit organic growth, strong operating leverage and disciplined capital allocation drove significant adjusted EPS growth, and that the company delivered 121% free-cash-flow conversion.

DuPont completed a $250 million accelerated share purchase and substantially completed $100 million of open-market share repurchases in the third quarter. It announced intent to repurchase $250 million of shares in the fourth quarter.

Chief Financial Officer Antonella Franzen said the company is again raising its full-year outlook and now expects organic growth of about 4.5%, operating EBITDA of about $1.785 billion and adjusted EPS of $7.47 to $7.52, all at or above the high end of previously communicated guidance. Fourth-quarter 2026 net sales are expected at about $1.83 billion, operating EBITDA at about $455 million, and adjusted EPS of $1.90 to $1.95. Franzen said continued strength across healthcare, aerospace and industrial water end-markets leaves the company well positioned to deliver attractive growth, strong cash generation and effective capital deployment.